Scilex Holding Co
SCLXW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $16.4K in total; no superinvestor holds it.
Other share classesSCLX
Q1 2025 vs. Q4 2024
How the institutions holding Scilex Holding Co changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 9 | 7 | −2 |
| Shares | 244.0K | 244.9K | +862 (+0.4%) |
| Value | $73.1K | $39.9K | −$33.3K (−45.5%) |
New holders (1)
Institutions that held Scilex Holding Co at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 12,179 | $1.68K | 0.00% |
Sold out (3)
Institutions that held Scilex Holding Co at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 10,899 | $2.29K |
| JPMorgan Chase & Co | – | $257 |
| Tower Research Capital LLC (TRC) | 418 | $88 |